What question did this study set out to answer?

This research emphasizes the necessity of long-term data in clinical trials for Crohn’s disease management.

April 28, 2026Inflammatory Bowel Diseases0 citations

Entering a new GALAXI: The importance of long-term data in Crohn’s disease clinical trials

JSJoseph Sleiman SOSara El Ouali NNNurulamin M Noor

Puntos clave

This research emphasizes the necessity of long-term data in clinical trials for Crohn’s disease management.
Reviewed existing clinical trial data on Crohn's disease.
Analyzed long-term outcomes compared to short-term results.
Highlighted gaps in data for better treatment decision-making.
Identified a significant lack of long-term data in existing trials.
Long-term insights can lead to improved therapy selection.
Better treatment strategies emerge from comprehensive data collection.

Resumen

Lay Summary Crohn’s disease is a chronic, lifelong condition, but there has been a notable absence of long-term data from clinical trials, with outcomes typically focused on shorter-term outcomes at 6 months, at 1 year, or at most 2 years. The growing amount of longer-term data from clinical trial programs is therefore welcome and valuable for patients to help guide on selection of appropriate therapies and treatment strategies.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo